A New Acycloguanosine-specific Supermutant of Herpes Simplex Virus Type 1 Thymidine Kinase Suitable for PET Imaging and Suicide Gene Therapy for Potential Use in Patients Treated with Pyrimidine-based Cytotoxic Drugs

Overview

Journal J Nucl Med

Specialty Nuclear Medicine

Date 2008 Apr 17

PMID 18413388

Citations 9

Authors

Yury Likar

Konstantin Dobrenkov

Malgorzata Olszewska

Elena Vider

Larissa Shenker

Shangde Cai

NagaVaraKishore Pillarsetty

Hedvig Hricak

Vladimir Ponomarev

Affiliations

Soon will be listed here.

Abstract

Unlabelled: The herpes simplex virus type 1 thymidine kinase (HSV1-tk) gene is widely used as a suicide gene in combination with ganciclovir (GCV) and as a nuclear imaging reporter gene with an appropriate reporter probe. Wild-type HSV1-tk recognizes a variety of pyrimidine and acycloguanosine nucleoside analogs, including clinically used antiviral drugs. PET of HSV1-tk reporter gene expression will be compromised in patients receiving nucleoside-based antiviral treatment. With the use of an acycloguanosine-specific mutant of the enzyme, PET of HSV1-tk reporter gene expression can be successfully performed with acycloguanosine-based radiotracers without interference from pyrimidine-based antiviral drugs.

Methods: The levels of expression of wild-type HSV1-tk and HSV1-A167Ytk, HSV1-sr39tk, and HSV1-A167Ysr39tk mutants fused with green fluorescent protein (GFP) and transduced into U87 cells were normalized to the mean fluorescence of GFP measured by fluorescence-activated cell sorting. The levels of enzymatic activities of wild-type HSV1-tk and its mutants were compared by 2-h in vitro radiotracer uptake assays with (3)H-2'-fluoro-2'-deoxy-1-beta-d-arabinofuranosyl-5-ethyluracil ((3)H-FEAU), (3)H-pencyclovir ((3)H-PCV), and (3)H-GCV and by drug sensitivity assays. PET with (18)F-FEAU and (18)F-9-[4-fluoro-3-(hydroxymethyl)butyl]guanine ((18)F-FHBG) was performed in mice with established subcutaneous tumors, expressing wild-type HSV1-tk and its mutants, followed by tissue sampling.

Results: FEAU accumulation was not detected in HSV1-A167Ysr39tk-expressing cells and xenografts. Lack of conversion of pyrimidine derivatives by the HSV1-A167Ysr39tk supermutant was also confirmed by a drug sensitivity assay, in which the 50% inhibitory concentrations for thymine 1-beta-d-arabinofuranoside and bromovinyldeoxyuridine were found to be similar to those in nontransduced cells. In contrast, we found that HSV1-A167Ysr39tk could readily phosphorylate (3)H-GCV at levels similar to those of wild-type HSV1-tk and HSV1-A167Ytk but showed enhanced activity with (3)H-PCV in vitro and with (18)F-FHBG in vivo.

Conclusion: We developed a new reporter gene, HSV1-A167Ysr39tk, which exhibits specificity and high phosphorylation activity for acycloguanosine derivatives. The resulting supermutant can be used for PET with (18)F-FHBG and suicidal gene therapy protocols with GCV in patients treated with pyrimidine-based cytotoxic drugs.

Citing Articles

Not gene therapy, but genetic surgery-the right strategy to attack cancer.

Sverdlov E Mol Gen Microbiol Virol. 2020; 24(3):93-113.

PMID: 32214647 PMC: 7089455. DOI: 10.3103/S089141680903001X.

Imaging grafted cells with [18F]FHBG using an optimized HSV1-TK mammalian expression vector in a brain injury rodent model.

Salabert A, Vaysse L, Beaurain M, Alonso M, Arribarat G, Lotterie J PLoS One. 2017; 12(9):e0184630.

PMID: 28926581 PMC: 5604981. DOI: 10.1371/journal.pone.0184630.

Comparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging.

Lee J, Zhang H, Moroz M, Likar Y, Shenker L, Sumzin N Mol Imaging Biol. 2016; 19(1):100-108.

PMID: 27393689 PMC: 5345744. DOI: 10.1007/s11307-016-0981-6.

An in vitro and in vivo evaluation of a reporter gene/probe system hERL/(18)F-FES.

Qin C, Lan X, He J, Xia X, Tian Y, Pei Z PLoS One. 2013; 8(4):e61911.

PMID: 23593502 PMC: 3625158. DOI: 10.1371/journal.pone.0061911.

Positron emission tomography (PET) imaging with (18)F-based radiotracers.

Alauddin M Am J Nucl Med Mol Imaging. 2012; 2(1):55-76.

PMID: 23133802 PMC: 3478111.

References

Moroz M, Serganova I, Zanzonico P, Ageyeva L, Beresten T, Dyomina E . Imaging hNET reporter gene expression with 124I-MIBG. J Nucl Med. 2007; 48(5):827-36. DOI: 10.2967/jnumed.106.037812. View

De Clercq E . Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster. Biochem Pharmacol. 2004; 68(12):2301-15. DOI: 10.1016/j.bcp.2004.07.039. View

Yaghoubi S, Barrio J, Dahlbom M, Iyer M, Namavari M, Satyamurthy N . Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med. 2001; 42(8):1225-34. View

Degreve B, Esnouf R, De Clercq E, Balzarini J . Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine. Mol Pharmacol. 2000; 58(6):1326-32. DOI: 10.1124/mol.58.6.1326. View

Moomaw M, Cornea P, Rathbun R, Wendel K . Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster. Expert Rev Anti Infect Ther. 2004; 1(2):283-95. DOI: 10.1586/14787210.1.2.283. View

Alauddin M, Shahinian A, Kundu R, Gordon E, Conti P . Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol. 1999; 26(4):371-6. DOI: 10.1016/s0969-8051(98)00116-4. View

Choi S, Zhuang Z, Chacko A, Acton P, Tjuvajev-Gelovani J, Doubrovin M . SPECT imaging of herpes simplex virus type1 thymidine kinase gene expression by [(123)I]FIAU(1). Acad Radiol. 2005; 12(7):798-805. DOI: 10.1016/j.acra.2005.04.010. View

Jacobs A, Braunlich I, Graf R, Lercher M, Sakaki T, Voges J . Quantitative kinetics of [124I]FIAU in cat and man. J Nucl Med. 2001; 42(3):467-75. View

Ponomarev V, Doubrovin M, Serganova I, Beresten T, Vider J, Shavrin A . Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging. Neoplasia. 2003; 5(3):245-54. PMC: 1502405. DOI: 10.1016/S1476-5586(03)80056-8. View

10.

Balatoni J, Doubrovin M, Ageyeva L, Pillarsetty N, Finn R, Gelovani J . Imaging herpes viral thymidine kinase-1 reporter gene expression with a new 18F-labeled probe: 2'-fluoro-2'-deoxy-5-[18F]fluoroethyl-1-beta-d-arabinofuranosyl uracil. Nucl Med Biol. 2005; 32(8):811-9. DOI: 10.1016/j.nucmedbio.2005.07.007. View

11.

Serganova I, Doubrovin M, Vider J, Ponomarev V, Soghomonyan S, Beresten T . Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice. Cancer Res. 2004; 64(17):6101-8. DOI: 10.1158/0008-5472.CAN-04-0842. View

12.

Moore A, Josephson L, Bhorade R, Basilion J, Weissleder R . Human transferrin receptor gene as a marker gene for MR imaging. Radiology. 2001; 221(1):244-50. DOI: 10.1148/radiol.2211001784. View

13.

Alauddin M, Shahinian A, Park R, Tohme M, Fissekis J, Conti P . In vivo evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil ([18F]FIAU) and 2'-deoxy-2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging. 2007; 34(6):822-9. DOI: 10.1007/s00259-006-0305-1. View

14.

Penuelas I, Mazzolini G, Boan J, Sangro B, Marti-Climent J, Ruiz M . Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology. 2005; 128(7):1787-95. DOI: 10.1053/j.gastro.2005.03.024. View

15.

Min J, Gambhir S . Gene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects. Gene Ther. 2004; 11(2):115-25. DOI: 10.1038/sj.gt.3302191. View

16.

Yaghoubi S, Couto M, Chen C, Polavaram L, Cui G, Sen L . Preclinical safety evaluation of 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk's expression. J Nucl Med. 2006; 47(4):706-15. View

17.

Yaghoubi S, Gambhir S . PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG. Nat Protoc. 2007; 1(6):3069-75. DOI: 10.1038/nprot.2006.459. View

18.

Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L . HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 1997; 276(5319):1719-24. DOI: 10.1126/science.276.5319.1719. View

19.

Alauddin M, Conti P . Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol. 1998; 25(3):175-80. DOI: 10.1016/s0969-8051(97)00160-1. View

20.

Alauddin M, Shahinian A, Gordon E, Conti P . Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo. Mol Imaging. 2003; 1(2):74-81. DOI: 10.1162/15353500200202100. View